Breaking News

Merz Acquires Neocutis S.A.

July 31, 2013

Physician dispensed skin care line has seen double digit growth in US.


 
Merz Pharma Group has entered into a definitive agreement with Swiss dermatology company Neocutis to acquire the privately held company’s cosmetics, OTC and Rx skin care business, which includes Neocutis, a line of physician-dispensed topical skin care products sold in the US.
 
Neocutis is an innovative company with an excellent presence in the US market, and a promising potential for development,” said Philip Burchard, CEO of Merz Pharma Group. “This transaction is an important step to expand our U.S. business, as Neocutis products are an excellent addition to our own aesthetics portfolio.”
 
According to Merz, the acquisition reflects a strategy to establish itself as a global leader in medical and aesthetic dermatology. Merz North America offers dermal fillers such as Radiesse Volumizing Filler, as well as Mederma, a skin care line for scar care and stretch marks therapy.
 
Neocutis S.A. was founded in February 2003 as a spin-off of the medical faculty of the Lausanne University Clinic, Switzerland. The privately owned company is headquartered in Lausanne, Switzerland and develops and distributes innovative cosmetic products for dermatologic conditions and anti-aging skincare. The company entered the US market in 2009 and since that time has seen double-digit growth annually, according to Merz.

Related End-User Markets:

blog comments powered by Disqus
  • Innovation On Display

    Melissa Meisel, Associate Editor||February 3, 2016
    P&G Beauty Digital Studio showcases new products for 2016

  • Burgeoning Beauty

    Burgeoning Beauty

    Melissa Meisel, Associate Editor||January 4, 2016
    A look at trailblazers for 2016 and beyond.

  • Testing for Sustainable Preservatives

    Adam P. Byrne, William Michael Hart-Cooper, Kaj Johnson, Larry H. Stanker, Dominic W. S. Wong, William J. Orts||January 4, 2016
    A rapid, inexpensive and qualitative protocol for determining microbial growth inhibition.